Learnings from #RareDisease #ClinicalDevelopment are shaping the future of medicine– from sharpened trial design discipline and innovation to deepened collaborations with patients, families, and other stakeholders around the world. #WeHearYou #Biosky
www.the-scientist.com/what-rare-di...

Looking for ways to reduce your #drugdevelopment timeline? This blog is for you!

Or, not know much about the time & costs involved in drug development & want to learn? This blog is for you, too!
www.fiosgenomics.com/reducing-the-drug-develo...
#clinicaldevelopment #bioinformatics

Gain actionable insights for biotech founders, clinical development leaders, medical affairs professionals, and emerging CMOs navigating the path from early development to launch.

Listen to the latest episode of our podcast: buff.ly/4IYeX3W

#MedicalAffairs #ClinicalDevelopment #EarlyStage #Biotech

These modules support clinicians working in paediatric services and those looking to develop specialist skills and progress their careers.

Find out more about the paediatric HTS modules: 🔗 https://baaudiology.org/careers/hts/

#PaediatricAudiology #AudiologyCareers #BAA #ClinicalDevelopment

Joint FIU-Baptist Health clinical site on track for 2028 use Development of a joint clinical site on the campus of Florida International University as part of its partnership with Baptist Health is on track to be completed in 2028. It’s “progressing extremel...

BREAKING NEWS: Joint FIU-Baptist Health clinical site on track for 2028 use

www.miamitodaynews.com/breaking/joi...

#MiamiTodayNews #FIU #BaptistHealth #FIUHealth #ClinicalDevelopment #MiamiToday

"I have no shortage of ideas. I just have a shortage of time." This is the reality for every innovator in #LifeSciences. Here is how AI is solving the "Time Shortage." (contd.) #Innovation #ClinicalDevelopment

As @fda.gov moves toward a single pivotal trial as the default path to approval, many of the biggest #ClinicalDevelopment #Bottlenecks are shifting downstream into document readiness. Let's rethink how and when your documents are built: www.synterex.com/services

Policy shift favors one pivotal trial, aiming to cut costs, speed access and reshape how therapies for aging reach patients.

vist.ly/4sqrh

#longevity #FDA #DrugApproval #RegulatoryReform #BiotechPolicy #ClinicalDevelopment #AgingTherapeutics #HealthEconomics

Moderna、mRNA-3927でRecordatiと協業──プロピオン酸血症（PA）治療の後期開発とグローバル商業化へ | STELLANEWS.LIFE STELLANEWS.LIFE（ステラニュース・ライフ）は、科学や技術、医薬品分野における最新の研究成果や発見 | STELLANEWS.LIFE（ステラニュース・ライフ）は、科学や技術、医薬品分野における最新の研究成果や発見

Moderna announced a collaboration with Recordati for mRNA-3927, an investigational therapy for propionic acidemia (PA), to advance late-stage clinical development and global commercialization.

stellanews.life/technology/8...

#PropionicAcidemia #mRNA #Moderna #Recordati #ClinicalDevelopment

Excited for OCT West Coast 2026 Feb 11–12!

Catch us at Booth 92 to connect, share insights, and explore patient-focused clinical trials.

Don’t miss Adam Callahan speaking Feb 12 at 9:30 AM on IND-to-approval strategies. 🤝

#OCTWestCoast #ClinicalTrials #ClinicalDevelopment #Oncology #Collaboration

Looking for ways to reduce your #drugdevelopment timeline? This blog is for you!

Or, not know much about the time & costs involved in drug development & want to learn? This blog is for you, too!
www.fiosgenomics.com/reducing-the-drug-develo...
#clinicaldevelopment #bioinformatics

🚀🔬Day 2 kicks off with Session Five at #ACC2026

Clinical development and use of new agents takes centre stage as we dive into how emerging treatments move from trials to practice.

🎥 Join us live now: portalapp.bsac.eventsair.com/VirtualAtten...

@gsk.bsky.social

#AMR #ClinicalDevelopment

Moderated by Dr. Yoshi Murata of Gilead.

This is the pipeline in action.

Register now: us06web.zoom.us/meeting/regi...

#HerpesScience #ClinicalDevelopment #HSVInnovation #CureResearch

#Moderna #skincancervaccine #MSD #mRNAbasedvaccine #melanoma #intismeranautogene #mRNA4157 #KEYNOTE942study #cancervaccine #highriskmelanoma #personalisedvaccine #cancerneoantigens #lungcancer #kidneycancer #bladdercancer #INTerpath001trial #solidtumours #oncology #clinicaldevelopment
zurl.co/fwe5k

Obesity, complexity, and the lab: What 2025 taught us, and what comes next The complexity of working with the patient population in obesity continues to challenge traditional trial design. hVIVO looks to the year ahead.

#Obesity #cardiometabolicdiseases #earlyphaseresearch #clinicaltrialdesign #clinicaldevelopment #clinicaltrialsponsors #weightloss #obesitydrivencomorbidities #GLP1receptoragonists #MASLD #patientrecruitment #Personalisedtrialdesign #obesitytrials #cardiometabolicsector
zurl.co/ErmB8

We're looking forward to next week's Disruptive Technology for Clinical Trials Europe 2026 meeting in London. If you'll be in attendance, email contact@lumanity.com to meet. buff.ly/HR8rC7J

#ClinicalTrialsEurope #RWE #ClinicalResearch #PatientSafety #ClinicalDevelopment

We're looking forward to next week's Disruptive Technology for Clinical Trials Europe 2026 meeting in London. If you'll be in attendance, email contact@lumanity.com to meet. buff.ly/HR8rC7J

#ClinicalTrialsEurope #RWE #ClinicalResearch #PatientSafety #ClinicalDevelopment

Access key strategies to ensure your organization makes the most of every #FDA interaction, shape development pathways, clarify regulatory expectations, and meaningfully reduce program risk: buff.ly/9zkotWO

#DrugDevelopment #RegulatoryAffairs #ClinicalDevelopment

Fortrea is joining industry leaders at #JPMWeek in San Francisco. We’re looking forward to connecting & exploring opportunities to advance #clinicaldevelopment & innovation together.
Our team will be available for partnering meetings all week. If you’re attending, let’s meet! #ClinicalResearch

Looking for ways to reduce your #drugdevelopment timeline? This blog is for you!

Or, not know much about the time & costs involved in drug development & want to learn? This blog is for you, too!
www.fiosgenomics.com/reducing-the-drug-develo...
#clinicaldevelopment #bioinformatics

Looking for ways to reduce your #drugdevelopment timeline? This blog is for you!

Or, not know much about the time & costs involved in drug development & want to learn? This blog is for you, too!
www.fiosgenomics.com/reducing-the-drug-develo...
#clinicaldevelopment #bioinformatics

Interactions with the U.S. #FDA represent some of the most pivotal moments in the product development lifecycle. Access key strategies to ensure your organization makes the most of every #FDA interaction: buff.ly/9zkotWO

#DrugDevelopment #RegulatoryStrategy #ClinicalDevelopment #RegulatoryAffairs

Looking for ways to reduce your #drugdevelopment timeline? This blog is for you!

Or, not know much about the time & costs involved in drug development & want to learn? This blog is for you, too!
www.fiosgenomics.com/reducing-the-drug-develo...
#clinicaldevelopment #bioinformatics

Tomorrow, Chad Glasser, VP of Clinical Research, will present at the Wellcome Mitochondrial Medicine Conference on assessing cognitive function in #PrimaryMitochondrialDisease clinical trials. #MELAS #ClinicalDevelopment #Biosky coursesandconferences.wellcomeconnectingscience.org/event/mitoch...

In a landscape where every day counts, the ROI on high-quality #MedicalWriting is real and measurable. Read our LinkedIn post for info about building trust with regulators, stakeholders, and patients: www.linkedin.com/company/synt...

#RegulatoryAffairs #DrugDevelopment #ClinicalDevelopment

AbbVie unveils new data on solid tumour therapies - PharmaTimes Phase 1 and phase 2 results highlight promise of ADCs for hard-to-treat cancers

#oncology #AbbVie #solidtumourtherapies #ADCs #antibodydrugconjugate #ADCplatform #solidtumours #ESMO2025 #pancreaticcancer #colorectalcancer #solidtumourtypes #ADCcandidates #clinicaldevelopment #innovativetherapies #patientoutcomes #clinicalstrategies #regulatory
zurl.co/AmIT3

Compliance is non-negotiable in this industry. But with the right integration strategy and the right partners, AI becomes a force multiplier. Read our post on LinkedIn for more insights: www.linkedin.com/company/synt...

#RegulatoryWriting #Compliance #ClinicalDevelopment #QualityAssurance

Services | Synterex | Synterex In rare disease development, regulatory decision-making often hinges on limited, non-traditional data. Common challenges that arise in the rare disease space include small sample sizes, single-arm or ...

In rare diseases, the “n of 1” matters, and efficacy narratives help tell that story with clarity and impact. For more on #EfficacyNarratives in #RareDiseases, read our latest LinkedIn post: www.linkedin.com/feed/update/...

#ClinicalDevelopment #RegulatoryStrategy #OrphanDrugs

We’re excited to join industry leaders at the Cell & Gene #MeetingOnTheMesa! At Fortrea, we’re advancing the future of #CellAndGeneTherapy.
👉 Schedule a 1:1 meeting with our team: www.fortrea.com/insights/events/fortrea-...
#CGMesa25 #ClinicalDevelopment

We’re proud to be a partner of the World Clinical Biomarkers & Companion Diagnostics Summit next week.

Join our plenary session with Jean-Francois Martini to learn how our flexible solutions combined with multimodal real-world data and can streamline your #ClinicalDevelopment program for success.